Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Accepted 2022-03-08 00:00:00 ET · period of report 2022-03-04 · accession 0001209191-22-017058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-08 | 2022-03-04+ | TEVA | Schultz Kare | Pres, CEO, Dir | M - OptEx | — | +293.6K | 1.43M | +26% | — |
| D | 2022-03-08 | 2022-03-04 | TEVA | Schultz Kare | Pres, CEO, Dir | A - Grant | $0.00 | +402.1K | 402.1K | New | $0 |
| DM | 2022-03-08 | 2022-03-04+ | TEVA | Schultz Kare | Pres, CEO, Dir | M - OptEx | $0.00 | -293.6K | 213.9K | -58% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-03-04 | M | A | 59,701 | — | 1,192,197 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 2 | Common | Ordinary Shares | 2022-03-04 | M | A | 162,593 | — | 1,354,790 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 3 | Common | Ordinary Shares | 2022-03-05 | M | A | 71,292 | — | 1,426,082 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 4 | Derivative | Restricted Share Units | 2022-03-04 | A | A | 402,144 | $0.00 | 402,144 | D | — · — to — | 402,144 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F5) Restricted share units were granted on March 4, 2022, with 100,536 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026. |
| 5 | Derivative | Restricted Share Units | 2022-03-04 | M | D | 162,593 | $0.00 | 0 | D | — · — to — | 162,593 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F4) Restricted share units were received on February 8, 2022 upon satisfaction of performance criteria and vested on March 4, 2022. |
| 6 | Derivative | Restricted Share Units | 2022-03-04 | M | D | 59,701 | $0.00 | 59,702 | D | — · — to — | 59,701 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F3) Restricted share units were granted on March 4, 2019, with 59,701 having vested on each of March 4, 2021 and March 4, 2022 and 59,702 vesting on March 4, 2023. |
| 7 | Derivative | Restricted Share Units | 2022-03-05 | M | D | 71,292 | $0.00 | 213,879 | D | — · — to — | 71,292 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F6) Restricted share units were granted on March 5, 2021, with 71,292 having vested on March 5, 2022, 71,292 vesting on each of March 5, 2023 and March 5, 2024, and 71,295 vesting on March 5, 2025. |